• Explore /
  • Poster
  • / Use of an antibody-drug conjugate targeting tissue factor to induce complete tumor regression in xenograft models with heterogeneous target expression.

Use of an antibody-drug conjugate targeting tissue factor to induce complete tumor regression in xenograft models with heterogeneous target expression.

Abstract Poster

Authors

null

Esther CW Breij

Genmab, Utrecht, Netherlands

Esther CW Breij , David Satijn , Sandra Verploegen , Bart de Goeij , Danita Schuurhuis , Wim Bleeker , Mischa Houtkamp , Paul Parren

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics - Immunotherapy

Track

Developmental Therapeutics

Sub Track

Immunotherapy and Biologic Therapy

Citation

J Clin Oncol 31, 2013 (suppl; abstr 3066)

DOI

10.1200/jco.2013.31.15_suppl.3066

Abstract #

3066

Poster Bd #

17A

Abstract Disclosures

Similar Posters

First Author: Esther CW Breij

First Author: Susanna Varkey Ulahannan

First Author: Ichiaki Ito

First Author: Lucy Swift